Specifically, YAP upregulates direct expression of SOX9 via transcription at the SOX9 promoter and endows CSC properties onto a wide variety of non-transformed cell types of gastrointestinal origin, including primary esophageal epithelium cells, immortalized embryonic liver cells as well as ESCC cells. Here, SOX9 is linked to esophageal squamous cell carcinoma.